Background: This study investigates the levels of fibroblast growth factor 23 (FGF23), Klotho, interleukin-6 (IL-6), interleukin-10 (IL-10), and myostatin (Mstn) in stable kidney transplant recipients undergoing triple immunosuppressive therapy. This evidence concerns the gene MSTN and medical procedure.